Cargando…
Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis
Th17 cells and their cytokines are linked to the pathogenesis of rheumatoid arthritis, a chronic autoimmune disease characterized by joint inflammation. Th17 development is initiated by combined signaling of TGF-β and IL-6 or IL-21, and can be reduced in the absence of either IL-6 or IL-21. The aim...
Autores principales: | Roeleveld, Debbie M., Marijnissen, Renoud J., Walgreen, Birgitte, Helsen, Monique M., van den Bersselaar, Liduine, van de Loo, Fons A., van Lent, Peter L., van der Kraan, Peter M., van den Berg, Wim B., Koenders, Marije I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291406/ https://www.ncbi.nlm.nih.gov/pubmed/28158305 http://dx.doi.org/10.1371/journal.pone.0171757 |
Ejemplares similares
-
Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis
por: van Nieuwenhuijze, Annemarie E. M., et al.
Publicado: (2015) -
Local inhibition of TGF-β1 signaling improves Th17/Treg balance but not joint pathology during experimental arthritis
por: Aarts, Joyce, et al.
Publicado: (2022) -
Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis
por: Rogier, Rebecca, et al.
Publicado: (2017) -
Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice
por: Aarts, Joyce, et al.
Publicado: (2020) -
Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice
por: Rogier, Rebecca, et al.
Publicado: (2019)